DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 1BORTEZOMIB
02 1GADOBUTROL
03 1LUSEDRA
04 1TORSEMIDE
Reset all filters
01 122244
02 190656
03 1206927
04 1217480
Reset all filters
01 4No
Drug : BORTEZOMIB
Dosage Form : POWDER; INTRAVENOUS
Application Number : 206927
Country : US
Patented : No
Drug : TORSEMIDE
Dosage Form : SOLUTION; INTRAVENOUS
Application Number : 90656
Country : US
Patented : No
Drug : LUSEDRA
Dosage Form : SOLUTION; INTRAVENOUS
Application Number : 22244
Country : US
Patented : No
Drug : GADOBUTROL
Dosage Form : SOLUTION; INTRAVENOUS
Application Number : 217480
Country : US
Patented : No